eClinical solutions Market By Product (Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Randomization and Trial Supply Management, Electronic Clinical Outcome Assessment, Electronic Trail Master Files, Other

eClinical solutions Market By Product (Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Randomization and Trial Supply Management, Electronic Clinical Outcome Assessment, Electronic Trail Master Files, Others), By Delivery Mode (Web-hosted, On-premise, Cloud-based), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

The global eClinical solutions market was valued at $6,816.17 million in 2021, and is estimated to reach $21,502.95 million by 2031, growing at a CAGR of 12.2% from 2022 to 2031.

eClinical solutions are software, which are used for effective management, and integration of data generated during clinical trials. It offers set of tools to effectively plan, manage, track clinical study portfolio and create insights. The major factors that drive the growth of the eClinical solutions market are decrease in time cycle, reduction in data duplication, and additional efforts taken by team carrying out clinical trial for sorting and integrating the data. 

In addition, eClinical solutions accelerates decision making as data is sorted and integrated by the software itself. It is a key trend of the market, which is expected to fuel the growth of the market during the forecast period. These solutions creates the demographic charts, mapping and comprehensive analytics that answer clinical and operational questions with speed and accuracy. Thus by centralizing data issues, errors are identified sooner and decision making process gets accelerated. Furthermore, significant surge in technological advancement is also one leading factors of this market as paper work takes much time, thus, managing enormous data makes individual frustrated. By using advanced technological solutions it becomes easier to manage data for the team carrying out clinical trials. Moreover, emerging markets are becoming a hub for the growth of eClinical solutions utilization owing to rise in the number of clinical trials. There are lot of opportunities for the market players to expand their business across developing economies due to availability of resources at lower rate and less regulatory policies for drug development. 

Augmentation of data, government initiatives for making better healthcare services assists the market growth in emerging markets. However, eClinical solutions required high initial capital cost and regular maintenance attempts, which impede the market growth. The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trials, end user, and region. On the basis of product, the market is categorized into electronic data capture (EDC) &clinical data management systems (CDMS), clinical trial management systems (CTMS), randomization & trial supply management (RTMS), electronic clinical outcome assessment (eCOA), electronic trial master file (eTMF), and others. 

On the basis of delivery mode, the market is segmented as web–hosted, on–premise, and cloud-based. On the basis of clinical trials, the market is segmented as Phase I, Phase II, Phase III, and Phase IV. On the basis of end users, the market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

The major players profiled in the report are Oracle Corporation, Parexel International Corporation (Calyx), DataTrak International, Inc., Dassault Systèmes (Medidata Solution, Inc.), Clario, Signant Health (CRF Health Inc.), eClinical Solutions, Inc., IBM Watson Health, Advarra, Inc. (Bio-Optronics, Inc.), MaxisIT Inc., Anju Software, Inc. Veeva Systems, Saama Technologies, Inc., Medrio, Inc., Castor EDC, Mednet, and Business Systems Integration AG.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the eClinical solutions market analysis from 2022 to 2031 to identify the prevailing eClinical solutions market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the eClinical solutions market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global eClinical solutions market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Delivery Mode

Web-hosted
On-premise
Cloud-based

By Clinical Trial Phase

Phase I
Phase II
Phase III
Phase IV

By Product

Clinical Trial Management Systems
Randomization and Trial Supply Management
Electronic Clinical Outcome Assessment
Electronic Trail Master Files
Others
Electronic Data Capture and Clinical Data Management Systems

By End User

Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Advarra, Inc. (Bio Optronics, Inc.)
Anju Software, Inc.
Business Systems Integration AG
Castor EDC
Clario
Dassault Systemes (Medidata Solution, Inc.)
DataTrak International, Inc.
eClinical Solutions, Inc.
IBM Watson Health
MaxisIT Inc.
MedNet Solutions
Medrio, Inc.
Parexel International Corporation (Calyx)
Saama Technologies, Inc.
Signant Health (CRF Health Inc.)
veeva systems
Oracle Corporation

Please Note: It will take 7-10 business days to complete the report upon order confirmation.


CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ECLINICAL SOLUTIONS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Electronic Data Capture and Clinical Data Management Systems
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Clinical Trial Management Systems
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Randomization and Trial Supply Management
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Electronic Clinical Outcome Assessment
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Electronic Trail Master Files
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
5.1 Overview
5.1.1 Market size and forecast
5.2 Web-hosted
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 On-premise
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Cloud-based
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
6.1 Overview
6.1.1 Market size and forecast
6.2 Phase I
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Phase II
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Phase III
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Phase IV
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: ECLINICAL SOLUTIONS MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Pharmaceutical and Biopharmaceutical Companies
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Contract Research Organizations
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: ECLINICAL SOLUTIONS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.3 North America Market size and forecast, by Delivery Mode
8.2.4 North America Market size and forecast, by Clinical Trial Phase
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Delivery Mode
8.2.6.1.3 Market size and forecast, by Clinical Trial Phase
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Delivery Mode
8.2.6.2.3 Market size and forecast, by Clinical Trial Phase
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Delivery Mode
8.2.6.3.3 Market size and forecast, by Clinical Trial Phase
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.3 Europe Market size and forecast, by Delivery Mode
8.3.4 Europe Market size and forecast, by Clinical Trial Phase
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Delivery Mode
8.3.6.1.3 Market size and forecast, by Clinical Trial Phase
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Delivery Mode
8.3.6.2.3 Market size and forecast, by Clinical Trial Phase
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Delivery Mode
8.3.6.3.3 Market size and forecast, by Clinical Trial Phase
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Delivery Mode
8.3.6.4.3 Market size and forecast, by Clinical Trial Phase
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Delivery Mode
8.3.6.5.3 Market size and forecast, by Clinical Trial Phase
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Delivery Mode
8.3.6.6.3 Market size and forecast, by Clinical Trial Phase
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.3 Asia-Pacific Market size and forecast, by Delivery Mode
8.4.4 Asia-Pacific Market size and forecast, by Clinical Trial Phase
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Delivery Mode
8.4.6.1.3 Market size and forecast, by Clinical Trial Phase
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Delivery Mode
8.4.6.2.3 Market size and forecast, by Clinical Trial Phase
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Delivery Mode
8.4.6.3.3 Market size and forecast, by Clinical Trial Phase
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Delivery Mode
8.4.6.4.3 Market size and forecast, by Clinical Trial Phase
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Delivery Mode
8.4.6.5.3 Market size and forecast, by Clinical Trial Phase
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Delivery Mode
8.4.6.6.3 Market size and forecast, by Clinical Trial Phase
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.3 LAMEA Market size and forecast, by Delivery Mode
8.5.4 LAMEA Market size and forecast, by Clinical Trial Phase
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Delivery Mode
8.5.6.1.3 Market size and forecast, by Clinical Trial Phase
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Delivery Mode
8.5.6.2.3 Market size and forecast, by Clinical Trial Phase
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Delivery Mode
8.5.6.3.3 Market size and forecast, by Clinical Trial Phase
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Delivery Mode
8.5.6.4.3 Market size and forecast, by Clinical Trial Phase
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Advarra, Inc. (Bio Optronics, Inc.)
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Anju Software, Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Business Systems Integration AG
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Castor EDC
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Clario
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Dassault Systemes (Medidata Solution, Inc.)
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 DataTrak International, Inc.
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 eClinical Solutions, Inc.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 IBM Watson Health
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 MaxisIT Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 MedNet Solutions
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Medrio, Inc.
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Parexel International Corporation (Calyx)
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Saama Technologies, Inc.
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 Signant Health (CRF Health Inc.)
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 veeva systems
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 Oracle Corporation
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. ECLINICAL SOLUTIONS MARKET SIZE, FOR ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. ECLINICAL SOLUTIONS MARKET SIZE, FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. ECLINICAL SOLUTIONS MARKET SIZE, FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 7. ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. ECLINICAL SOLUTIONS MARKET SIZE, FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 9. ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. ECLINICAL SOLUTIONS MARKET SIZE, FOR ELECTRONIC TRAIL MASTER FILES, BY REGION, 2021-2031 ($MILLION)
TABLE 11. ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRAIL MASTER FILES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. ECLINICAL SOLUTIONS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. ECLINICAL SOLUTIONS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 15. ECLINICAL SOLUTIONS MARKET SIZE, FOR WEB-HOSTED, BY REGION, 2021-2031 ($MILLION)
TABLE 16. ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. ECLINICAL SOLUTIONS MARKET SIZE, FOR ON-PREMISE, BY REGION, 2021-2031 ($MILLION)
TABLE 18. ECLINICAL SOLUTIONS MARKET FOR ON-PREMISE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. ECLINICAL SOLUTIONS MARKET SIZE, FOR CLOUD-BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 20. ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 22. ECLINICAL SOLUTIONS MARKET SIZE, FOR PHASE I, BY REGION, 2021-2031 ($MILLION)
TABLE 23. ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. ECLINICAL SOLUTIONS MARKET SIZE, FOR PHASE II, BY REGION, 2021-2031 ($MILLION)
TABLE 25. ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. ECLINICAL SOLUTIONS MARKET SIZE, FOR PHASE III, BY REGION, 2021-2031 ($MILLION)
TABLE 27. ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. ECLINICAL SOLUTIONS MARKET SIZE, FOR PHASE IV, BY REGION, 2021-2031 ($MILLION)
TABLE 29. ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. ECLINICAL SOLUTIONS MARKET SIZE, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 32. ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. ECLINICAL SOLUTIONS MARKET SIZE, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 34. ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. ECLINICAL SOLUTIONS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 36. ECLINICAL SOLUTIONS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. ECLINICAL SOLUTIONS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 38. NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 40. NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 41. NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 43. U.S. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. U.S. ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 45. U.S. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 46. U.S. ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. CANADA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. CANADA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 49. CANADA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 50. CANADA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. MEXICO ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. MEXICO ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 53. MEXICO ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 54. MEXICO ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. EUROPE ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 57. EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 58. EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. EUROPE ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 60. GERMANY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. GERMANY ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 62. GERMANY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 63. GERMANY ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. FRANCE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. FRANCE ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 66. FRANCE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 67. FRANCE ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. U.K. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. U.K. ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 70. U.K. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 71. U.K. ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. ITALY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. ITALY ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 74. ITALY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 75. ITALY ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. SPAIN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. SPAIN ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 78. SPAIN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 79. SPAIN ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 82. REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 83. REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 86. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 87. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 89. JAPAN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 90. JAPAN ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 91. JAPAN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 92. JAPAN ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. CHINA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. CHINA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 95. CHINA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 96. CHINA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. INDIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. INDIA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 99. INDIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 100. INDIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 103. AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 104. AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 105. SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 107. SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 108. SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 110. REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 111. REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 112. REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 113. LAMEA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 114. LAMEA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 115. LAMEA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 116. LAMEA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 117. LAMEA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 118. BRAZIL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 119. BRAZIL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 120. BRAZIL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 121. BRAZIL ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 122. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 123. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 124. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 125. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 126. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 127. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 128. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 129. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 130. REST OF LAMEA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 131. REST OF LAMEA ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2031 ($MILLION)
TABLE 132. REST OF LAMEA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2031 ($MILLION)
TABLE 133. REST OF LAMEA ECLINICAL SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 134.ADVARRA, INC. (BIO OPTRONICS, INC.): COMPANY SNAPSHOT
TABLE 135.ADVARRA, INC. (BIO OPTRONICS, INC.): OPERATING SEGMENTS
TABLE 136.ADVARRA, INC. (BIO OPTRONICS, INC.): PRODUCT PORTFOLIO
TABLE 137.ADVARRA, INC. (BIO OPTRONICS, INC.): NET SALES,
TABLE 138.ADVARRA, INC. (BIO OPTRONICS, INC.): KEY STRATERGIES
TABLE 139.ANJU SOFTWARE, INC.: COMPANY SNAPSHOT
TABLE 140.ANJU SOFTWARE, INC.: OPERATING SEGMENTS
TABLE 141.ANJU SOFTWARE, INC.: PRODUCT PORTFOLIO
TABLE 142.ANJU SOFTWARE, INC.: NET SALES,
TABLE 143.ANJU SOFTWARE, INC.: KEY STRATERGIES
TABLE 144.BUSINESS SYSTEMS INTEGRATION AG: COMPANY SNAPSHOT
TABLE 145.BUSINESS SYSTEMS INTEGRATION AG: OPERATING SEGMENTS
TABLE 146.BUSINESS SYSTEMS INTEGRATION AG: PRODUCT PORTFOLIO
TABLE 147.BUSINESS SYSTEMS INTEGRATION AG: NET SALES,
TABLE 148.BUSINESS SYSTEMS INTEGRATION AG: KEY STRATERGIES
TABLE 149.CASTOR EDC: COMPANY SNAPSHOT
TABLE 150.CASTOR EDC: OPERATING SEGMENTS
TABLE 151.CASTOR EDC: PRODUCT PORTFOLIO
TABLE 152.CASTOR EDC: NET SALES,
TABLE 153.CASTOR EDC: KEY STRATERGIES
TABLE 154.CLARIO: COMPANY SNAPSHOT
TABLE 155.CLARIO: OPERATING SEGMENTS
TABLE 156.CLARIO: PRODUCT PORTFOLIO
TABLE 157.CLARIO: NET SALES,
TABLE 158.CLARIO: KEY STRATERGIES
TABLE 159.DASSAULT SYSTEMES (MEDIDATA SOLUTION, INC.): COMPANY SNAPSHOT
TABLE 160.DASSAULT SYSTEMES (MEDIDATA SOLUTION, INC.): OPERATING SEGMENTS
TABLE 161.DASSAULT SYSTEMES (MEDIDATA SOLUTION, INC.): PRODUCT PORTFOLIO
TABLE 162.DASSAULT SYSTEMES (MEDIDATA SOLUTION, INC.): NET SALES,
TABLE 163.DASSAULT SYSTEMES (MEDIDATA SOLUTION, INC.): KEY STRATERGIES
TABLE 164.DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 165.DATATRAK INTERNATIONAL, INC.: OPERATING SEGMENTS
TABLE 166.DATATRAK INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 167.DATATRAK INTERNATIONAL, INC.: NET SALES,
TABLE 168.DATATRAK INTERNATIONAL, INC.: KEY STRATERGIES
TABLE 169.ECLINICAL SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 170.ECLINICAL SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 171.ECLINICAL SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 172.ECLINICAL SOLUTIONS, INC.: NET SALES,
TABLE 173.ECLINICAL SOLUTIONS, INC.: KEY STRATERGIES
TABLE 174.IBM WATSON HEALTH: COMPANY SNAPSHOT
TABLE 175.IBM WATSON HEALTH: OPERATING SEGMENTS
TABLE 176.IBM WATSON HEALTH: PRODUCT PORTFOLIO
TABLE 177.IBM WATSON HEALTH: NET SALES,
TABLE 178.IBM WATSON HEALTH: KEY STRATERGIES
TABLE 179.MAXISIT INC.: COMPANY SNAPSHOT
TABLE 180.MAXISIT INC.: OPERATING SEGMENTS
TABLE 181.MAXISIT INC.: PRODUCT PORTFOLIO
TABLE 182.MAXISIT INC.: NET SALES,
TABLE 183.MAXISIT INC.: KEY STRATERGIES
TABLE 184.MEDNET SOLUTIONS: COMPANY SNAPSHOT
TABLE 185.MEDNET SOLUTIONS: OPERATING SEGMENTS
TABLE 186.MEDNET SOLUTIONS: PRODUCT PORTFOLIO
TABLE 187.MEDNET SOLUTIONS: NET SALES,
TABLE 188.MEDNET SOLUTIONS: KEY STRATERGIES
TABLE 189.MEDRIO, INC.: COMPANY SNAPSHOT
TABLE 190.MEDRIO, INC.: OPERATING SEGMENTS
TABLE 191.MEDRIO, INC.: PRODUCT PORTFOLIO
TABLE 192.MEDRIO, INC.: NET SALES,
TABLE 193.MEDRIO, INC.: KEY STRATERGIES
TABLE 194.PAREXEL INTERNATIONAL CORPORATION (CALYX): COMPANY SNAPSHOT
TABLE 195.PAREXEL INTERNATIONAL CORPORATION (CALYX): OPERATING SEGMENTS
TABLE 196.PAREXEL INTERNATIONAL CORPORATION (CALYX): PRODUCT PORTFOLIO
TABLE 197.PAREXEL INTERNATIONAL CORPORATION (CALYX): NET SALES,
TABLE 198.PAREXEL INTERNATIONAL CORPORATION (CALYX): KEY STRATERGIES
TABLE 199.SAAMA TECHNOLOGIES, INC.: COMPANY SNAPSHOT
LIST OF FIGURES
FI

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings